Pharmaceutical product

摘要

The invention relates to the coadministration in human or veterinary medicine of a systemic, non-steroidal antiinflammatory drug and sufotidine or its physiologically acceptable salt. The two active ingredients, which can be administered separately or combined in a single product, are useful for the treatment of inflammatory states.